Ascendis Pharma A/S (ASND)

235.39 +6.74 (+2.95%) USD  |  NASDAQ  |  Jan 23, 16:00
240.00 +4.61 (+1.96%) After-Hours: 20:00
More

Ascendis Pharma CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Evaxion AS --
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --